
-
抗体試薬
- フローサイトメトリー用試薬
-
ウェスタンブロッティング抗体試薬
- イムノアッセイ試薬
-
シングルセル試薬
- BD® AbSeq Assay
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Immune Profiler Protein Panel
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD® OMICS-Guard Sample Preservation Buffer
- BD Rhapsody™ ATAC-Seq Assays
-
細胞機能評価のための試薬
-
顕微鏡・イメージング用試薬
-
細胞調製・分離試薬
-
- BD® AbSeq Assay
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Immune Profiler Protein Panel
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD® OMICS-Guard Sample Preservation Buffer
- BD Rhapsody™ ATAC-Seq Assays
- Japan (Japanese)
-
Change country/language
Old Browser
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
BD Pharmingen™ Purified Rat anti-Mouse GRAIL
クローン H11-744 (RUO)






Western blot analysis of mouse GRAIL. Lysates from four cell lines were probed with 1 µg/mL of the purified rat anti-mouse GRAIL monoclonal antibody (clone H11-744). Lane 1: NIH/3T3 retrovirally transduced with a tagged Rnf128 gene. Lane 2: NIH/3T3 retrovirally transduced with the vector alone. Lane 3: Hepa 1-6 (mouse hepatoma, ATCC CRL-1830). Lane 4: NIH/3T3 (mouse embryo fibroblasts, ATCC CRL-1658). GRAIL is identified here on transfected cells as a doublet of 75-80 kDa as opposed to the 62-66 kDa size reported to be in cells expressing GRAIL endogenously.

Immunocytochemical staining of mouse GRAIL. Chamber slide cultures of NIH/3T3 retrovirally transduced with the Rnf128 gene (top row) and NIH/3T3 retrovirally transduced with vector alone (bottom row) were fixed with 2% paraformaldehyde. They were stained with either purified rat IgG2a, κ isotype control mAb (Cat. No. 559073, left column) or purified rat anti-mouse GRAIL (right column). A three-step staining procedure that employs biotin goat anti-rat IgG secondary antibody (Cat. No. 559286), streptavidin-HRP (Cat. No. 550946) and DAB (Cat. No. 550880) and hematoxylin counterstaining were used. GRAIL staining is localized in the cytoplasm of the GRAIL-expressing cells (top right panel). Original magnification: 20X.


BD Pharmingen™ Purified Rat anti-Mouse GRAIL

BD Pharmingen™ Purified Rat anti-Mouse GRAIL

Regulatory Statusの凡例
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Preparation and Storage
Product Notices
- Since applications vary, each investigator should titrate the reagent to obtain optimal results.
- Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
関連製品





The H11-744 antibody reacts with GRAIL (Gene Related to Anergy In Lymphocytes protein), a 428-amino acid glycoprotein with an apparent molecular weight of 62-66 kDa that is preferentially expressed in anergized CD4-positive CD25-negative T lymphocytes. The GRAIL protein sequence is homologous to several zinc RING finger-containing proteins, and thus, its gene has been designated Rnf128 (RING finger protein 128). Rnf128 transcripts are found in several mouse organs (including ovary, kidney, liver, brain, and heart), and transcription is induced rapidly (within 4 hours) in CD4-positive T cells upon in vitro induction of anergy. The expression of GRAIL correlates with the inhibition of IL-2 production in in vitro-anergized CD4-positive CD25-negative T cells, and GRAIL expression reduces IL-2 and IL-4 production in T-cell hybridomas activated by plate-bound anti-CD3 plus anti-CD28. GRAIL protein is localized in the recycling endosomal compartment, functions as an E3 ubiquitin ligase, and is required for anergy induction of CD4-positive T cells in vivo.
This product is sold under a license to patent number US 6,709,840.
Development References (6)
-
Anandasabapathy N, Ford GS, Bloom D, et al. GRAIL: An E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity. 2003; 18:535-547. (Biology: Western blot). View Reference
-
Ermann J, Szanya V, Ford GS, Paragas V, Fathman CG, Lejon K. CD4-positive CD25-positive T cells facilitate the induction of T cell anergy. J Immunol. 2001; 167:4271-4275. (Biology). View Reference
-
Joazeiro CAP, Weissman AM. RING finger proteins: mediators of ubiquitin ligase activity. Cell. 2000; 102:549-552. (Biology). View Reference
-
Mueller DL. E3 ubiquitin ligases as T cell anergy factors. Nat Immunol. 2004; 5(9):883-890. (Biology).
-
Seroogy CM, Soares L, Ranheim EA, et al. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells. J Immunol. 2004; 173:79-85. (Biology). View Reference
-
Soares L, Seroogy C, Skrenta H, et al. Two isoforms of otubain 1 regulate T cell anergy via GRAIL. Nat Immunol. 2004; 5:45-54. (Immunogen: Western blot). View Reference
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.